Project: Gut-To-Blood: a platform for oral systemic delivery of targeted therapies

Acronym	G2B (Reference Number: 114171)
Duration	01/10/2020 - 01/10/2023
Project Topic	The partners are going to develop a unique platform for oral systemic delivery of targeted therapies. At the end of the project a Gut-To-Blood (G2B) Shuttle will be ready for partnering with Pharmaceutical companies to develop orally available molecules to treat chronic systemic diseases such as inflammatory autoimmune diseases, metabolic diseases, genetic disorders, etc… A second deliverable will be a molecule to treat rheumatoid arthritis (RA), developed as a proof-of-concept of the platform.
Network	Eurostars 2
Call	Eurostars Cut–off 13

Project partner

Number	Name	Role	Country
1	Affilogic SAS	Coordinator	France
2	ARTOIS UNIVERSITY, Public Scientific Cultural and Professional Establishment	Partner	France
3	TECHNISCHE UNIVERSITEIT EINDHOVEN	Partner	Netherlands
4	University of Geneva	Partner	Switzerland